New research, including two studies presented this week at the 43rd Annual Meeting of the European Association for the Study of Diabetes (EASD), further support the cardiovascular safety of ACTOS (pioglitazone HCI) and its benefits regarding improved blood glucose and blood lipid levels for patients with type 2 diabetes.
Immune cells from “cancer-resistant” people are to be injected into those with cancer to help fight the disease. Zheng Cui at Wake Forest University of Medicine in Winston-Salem, North Carolina, and his colleagues have received permission from the US Food and Drug Administration (FDA) to screen people for their ability to ward off cancer.
Gynecomastia, the benign enlargement of male breast tissue, is a common occurrence in adolescents as well as in middle-aged and older men. While there are several reasons why men develop breast tissue, it is usually not a health concern, often resolves on its own, and is generally treatable, according to a clinical practice article appearing in the September 20 issue of the New England Journal of Medicine (NEJM).
Rochester has been chosen as one of four national sites to monitor the effectiveness of the new cervical cancer vaccine. The project, which is funded by the national Centers for Disease Control and Prevention (CDC), will be jointly conducted by the University of Rochester Medical Center (URMC) and the New York State Department of Health.
The U.S. Food and Drug Administration has cleared for marketing the first rapid test to detect bacterial contamination in blood platelets prior to transfusion.
Dole Fresh Vegetables, a division of Dole Food Company, Inc. is voluntarily recalling all salad bearing the label “Dole Hearts Delight” sold in the U.S. and Canada with a “best if used by (BIUB)” date of September_19, 2007, and a production code of “A24924A” or “A24924B” stamped on the package.
The U.S. Food and Drug Administration approved expanding the population for use of the nasal influenza vaccine FluMist to include children between the ages of 2 and 5.
The Bill & Melinda Gates Foundation announced grants totaling $280 million to help fight tuberculosis, an epidemic that infects one-third of people on earth and kills nearly 2 million yearly—mostly in the poorest countries.
Attorney General Andrew M. Cuomo and New York City Mayor Michael Bloomberg filed a joint lawsuit against the maker of Vioxx for misrepresenting the dangers the drug posed to its users.
Uncontrolled patients with type 2 diabetes treated with metformin, one of the most prescribed oral medicines for this disease, were four times more likely to achieve recommended blood sugar control levels by adding Galvus® (vildagliptin) to their treatment compared to those who added a placebo, according to new clinical data[1].